Table 3. Baseline Characteristics for Women with CompleteA versus Incomplete Compliance with PMTCT Care Cascade.
Variable | Completed PMTCT Care Cascade (N=20,679) | Incomplete Compliance with Care Cascade (N=10,825) | |||
---|---|---|---|---|---|
Median (IQR)B | N available for analysis | Median (IQR)B | N available for analysis | P-value | |
Maternal age at 1st visit (years) | 30 (27-34) | 20,111 | 30 (26-34) | 10,244 | <0.0001 |
Gestational Age at 1st visit (weeks) | 23 (17-29) | 19,005 | 22 (16-29) | 9776 | <0.001 |
CD4 count at baseline (cells/mm3) | 363 (240-516) | 17,904 | 359 (223-522) | 8620 | 0.039 |
Viral load at baseline (copies/mL) | 603 (200-16026) | 15,109 | 1626 (200-29638) | 6857 | <0.0001 |
ARV Status, (%) | 20,679 | 10,825 | <0.0001D | ||
NNRTI-based ART/prophylaxis | 72% | 65% | <0.0001 | ||
PI-based ART | 7% | 6% | <0.0001 | ||
Triple-NRTI ART | 0.4% | 0.2% | <0.02 | ||
Mono/dual-NRTI prophylaxis | 12% | 10% | <0.0001 | ||
Single-dose NVP only | 0.2% | 0.2% | 0.6 | ||
No ARVs received or none documentedC | 8% | 19% | <0.0001 |
Complete compliance requires a minimum of one antenatal, delivery, and at least 1 infant follow-up visit.
All values reported in median (IQR) unless otherwise specified
No evidence of ARV receipt in database due to multiple factors: LTFU, non-eligible and <28 weeks (2006 guidelines), not documented.
Chi-square test was used for overall comparison of ARV regimens between those with complete and incomplete care compliance; Student's t-test was used for individual ARV comparisons.